Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice
Keywords: 2ME, 2-mercaptoethanol; ACN, acetonitrile; APF, 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]benzoic acid; CK, creatine kinase; CS, citrate synthase; CTAB, hexadecyltrimethylammonium bromide; DMD, Duchenne muscular dystrophy; DTNB, 5,5′-dithiobis-(2-nitrob